ArticleIntensive care medicine experimental2025
Transesophageal lung ultrasound score is associated with arterial oxygenation and clinical outcomes in mechanically ventilated critically ill patients.
Article in Intensive care medicine experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTransesophageal lung ultrasound (TELUS) has emerged as a novel modality that utilizes the esophageal acoustic window to obtain high-resolution images of posterior lung regions. However, its quantitative assessment and clinical relevance remain poorly explored. This study aimed to evaluate the feasibility and prognostic value of TELUS in critically ill patients, focusing on its association with arterial oxygenation and 28-day mortality.
methodsIn this prospective observational study, TELUS was performed in 69 mechanically ventilated ICU patients. TELUS imaging was acquired at three esophageal levels corresponding to posterior apical, mid, and basal lung regions. A semi-quantitative TELUS score was derived and its correlation with clinical variables was analyzed. Univariate and multivariate logistic regression analyses were employed to identify predictors of 28-day mortality. Receiver operating characteristic (ROC) analysis was used to assess the predictive performance of TELUS for mortality and severe hypoxemia (PaO₂/FiO₂ ≤ 100).
resultsNon-survivors had significantly higher TELUS scores compared to survivors (median 5 [IQR 4-6] vs. 4 [3-5], P = 0.001). Regional TELUS scores at the upper-aortic arch level and mid-esophageal level were elevated in non-survivors (P = 0.018 and P = 0.004, respectively). TELUS scores showed a significantly negative correlation with the PaO₂/FiO₂ ratio (r = -0.51, P < 0.0001), and positive correlations with PEEP (r = 0.32, P = 0.007) and SOFA scores (r = 0.26, P = 0.032). Multivariate analysis identified both SOFA (OR 1.31, 95% CI 1.08-1.63, P = 0.009) and TELUS scores (OR 1.72, 95% CI 1.08-2.96, P = 0.030) as independent predictors of 28-day mortality. ROC analysis showed that a TELUS score ≥ 4 predicted 28-day mortality and severe hypoxemia (PaO₂/FiO₂ ≤ 100), yielding areas under the ROC (AUCs) of 0.74 and 0.72, with high sensitivity (89% and 100%, respectively) and negative predictive values (92% and 100%, respectively.)
conclusionTELUS is a feasible novel technique that provides a reliable assessment of posterior lung aeration in critically ill patients. TELUS scoring correlates with impaired oxygenation and is independently associated with 28-day mortality. These findings highlight the prognostic value of TELUS and support its potential integration into transesophageal cardiopulmonary ultrasound protocols.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.